A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial
Journal article
Sackley, C. M., Rick, C., Au, P., Brady, M. C., Beaton, G., Burton, C., Caulfield, M., Dickson, S., Dowling, F., Hughes, M., Ives, N., Jowett, S., Masterton-Algar, P., Nicoll, A., Patel, S., Smith, C. H., Woolley, R. and Clarke, C. E. 2020. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial. Trials. 21 (436). https://doi.org/10.1186/s13063-020-04354-7
Authors | Sackley, C. M., Rick, C., Au, P., Brady, M. C., Beaton, G., Burton, C., Caulfield, M., Dickson, S., Dowling, F., Hughes, M., Ives, N., Jowett, S., Masterton-Algar, P., Nicoll, A., Patel, S., Smith, C. H., Woolley, R. and Clarke, C. E. |
---|---|
Abstract | Background Methods/design Primary outcome: Voice Handicap Index (VHI) total score at 3 months. Secondary outcomes include: VHI subscales, Parkinson’s Disease Questionnaire-39; Questionnaire on Acquired Speech Disorders; EuroQol-5D-5 L; ICECAP-O; resource utilisation; adverse events and carer quality of life. Mixed-methods process and health economic evaluations will take place alongside the trial. Assessments will be completed before randomisation and at 3, 6 and 12 months after randomisation. The trial started in December 2015 and will run for 77 months. Recruitment will take place in approximately 42 sites around the UK. Discussion Trial registration |
Keywords | Parkinson's disease; Speech and language therapy; Lee Silverman Voice Treatment |
Year | 2020 |
Journal | Trials |
Journal citation | 21 (436) |
Publisher | BioMed Central |
ISSN | 1745-6215 |
Digital Object Identifier (DOI) | https://doi.org/10.1186/s13063-020-04354-7 |
Official URL | https://doi.org/10.1186/s13063-020-04354-7 |
Publication dates | |
Online | 27 May 2020 |
Publication process dates | |
Accepted | 27 Apr 2020 |
Deposited | 02 Jun 2020 |
Output status | Published |
https://repository.canterbury.ac.uk/item/8v9y1/a-multicentre-randomised-controlled-trial-to-compare-the-clinical-and-cost-effectiveness-of-lee-silverman-voice-treatment-versus-standard-nhs-speech-and-language-therapy-versus-control-in-parkinson-s
150
total views0
total downloads0
views this month0
downloads this month